Cardiovascular Syst
(CSII)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,843 | 62,850 | 66,424 | 66,953 | 65,865 |
| Marketable Securities | 72,159 | 80,898 | 93,409 | 105,098 | 110,675 |
| Receivables | 40,232 | 40,259 | 39,678 | 34,666 | 34,944 |
| Inventories | 41,191 | 37,944 | 34,567 | 32,854 | 31,671 |
| TOTAL | $221,960 | $231,076 | $241,846 | $245,313 | $247,997 |
| Non-Current Assets | |||||
| PPE Net | 30,002 | 28,959 | 29,035 | 29,097 | 29,397 |
| Investments And Advances | 42,034 | 34,027 | 33,425 | 30,733 | 29,666 |
| Intangibles | 15,043 | 15,388 | 15,734 | 16,080 | 16,426 |
| Other Non-Current Assets | 2,467 | 2,588 | 2,637 | 2,768 | 2,914 |
| TOTAL | $89,546 | $80,962 | $80,831 | $78,678 | $78,403 |
| Total Assets | $311,506 | $312,038 | $322,677 | $323,991 | $326,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,087 | 16,757 | 14,383 | 13,598 | 12,493 |
| Accrued Expenses | 19,149 | 19,704 | 23,464 | 30,011 | 26,666 |
| TOTAL | $36,761 | $37,155 | $39,954 | $46,421 | $41,880 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,117 | 20,208 | 20,298 | 20,385 | 20,456 |
| Deferred Revenues | 525 | 694 | 2,107 | 2,812 | 2,721 |
| Other Non-Current Liabilities | 11,874 | 12,522 | 12,945 | 3,687 | 3,787 |
| TOTAL | $35,356 | $32,730 | $33,243 | $24,072 | $24,995 |
| Total Liabilities | $72,117 | $69,885 | $73,197 | $70,493 | $66,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,959 | 41,882 | 40,965 | 40,785 | 40,579 |
| Common Shares | 40 | 40 | 40 | 39 | 39 |
| Retained earnings | -443,413 | -435,502 | -423,680 | -413,881 | -404,116 |
| Other shareholders' equity | -170 | -271 | -268 | -212 | -58 |
| TOTAL | $239,389 | $242,153 | $249,480 | $253,498 | $259,525 |
| Total Liabilities And Equity | $311,506 | $312,038 | $322,677 | $323,991 | $326,400 |